Suscribirse

Effects of home-based EEG neurofeedback training as a non-pharmacological intervention for Parkinson's disease - 10/07/24

Doi : 10.1016/j.neucli.2024.102997 
Andrew Cooke a, b, , John Hindle c, d, Catherine Lawrence e, f, Eduardo Bellomo a, Aaron W. Pritchard d, Catherine A. MacLeod g, Pam Martin-Forbes h, Sally Jones h, Martyn Bracewell b, i, j, David E.J. Linden k, l, m, David M.A. Mehler l, m, n, o, p
a Instutute for the Psychology of Elite Performance (IPEP), Bangor University, UK 
b School of Psychology and Sport Science, Bangor University, UK 
c The Centre for Research in Ageing and Cognitive Health (REACH), University of Exeter, UK 
d University of Exeter Medical School, UK 
e Centre for Health Economics and Medicines Evaluation (CHEME), Bangor University, UK 
f School of Health Sciences, Bangor University, UK 
g Centre for Population Health Sciences, Usher Institute, The University of Edinburgh, UK 
h Betsi Cadwaladr University Health Board, UK 
i North Wales Medical School, Bangor University, UK 
j Walton Centre NHS Foundation Trust, UK 
k School for Mental Health and Neuroscience, Faculty of Health, Medicine and Life Sciences, Maastricht University, The Netherlands 
l Cardiff University Brain Research Imaging Centre (CUBRIC), School of Psychology, Cardiff University, UK 
m MRC Center for Neuropsychiatric Genetics and Genomics, School of Medicine, Cardiff University, UK 
n Division of Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff University, UK 
o Department of Psychiatry, Psychotherapy and Psychosomatics, Medical School, RWTH Aachen University, Germany 
p Institute for Translational Psychiatry, University Hospital Münster, Germany 

Corresponding author.

Abstract

Objectives

Aberrant movement-related cortical activity has been linked to impaired motor function in Parkinson's disease (PD). Dopaminergic drug treatment can restore these, but dosages and long-term treatment are limited by adverse side-effects. Effective non-pharmacological treatments could help reduce reliance on drugs. This experiment reports the first study of home-based electroencephalographic (EEG) neurofeedback training as a non-pharmacological candidate treatment for PD. Our primary aim was to test the feasibility of our EEG neurofeedback intervention in a home setting.

Methods

Sixteen people with PD received six home visits comprising symptomology self-reports, a standardised motor assessment, and a precision handgrip force production task while EEG was recorded (visits 1, 2 and 6); and 3 × 1-hr EEG neurofeedback training sessions to supress the EEG mu rhythm before initiating handgrip movements (visits 3 to 5).

Results

Participants successfully learned to self-regulate mu activity, and this appeared to expedite the initiation of precision movements (i.e., time to reach target handgrip force off-medication pre-intervention = 628 ms, off-medication post-intervention = 564 ms). There was no evidence of wider symptomology reduction (e.g., Movement Disorder Society Unified Parkinson's Disease Rating Scale Part III Motor Examination, off-medication pre-intervention = 29.00, off-medication post intervention = 30.07). Interviews indicated that the intervention was well-received.

Conclusion

Based on the significant effect of neurofeedback on movement-related cortical activity, positive qualitative reports from participants, and a suggestive benefit to movement initiation, we conclude that home-based neurofeedback for people with PD is a feasible and promising non-pharmacological treatment that warrants further research.

El texto completo de este artículo está disponible en PDF.

Keywords : Neurofeedback, Eeg, Parkinson's disease, Home-based, Intervention, Non-pharmacological


Esquema


© 2024  The Author(s). Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 54 - N° 5

Artículo 102997- septembre 2024 Regresar al número
Artículo precedente Artículo precedente
  • Posterior insula repetitive transcranial magnetic stimulation for chronic pain in patients with Parkinson disease – pain type matters: A double-blinded randomized sham-controlled trial
  • Victor Rossetto Barboza, Gabriel Taricani Kubota, Valquíria Aparecida da Silva, Luciana Mendonça Barbosa, Debora Arnaut, Antônia Lilian de Lima Rodrigues, Ricardo Galhardoni, Egberto Reis Barbosa, Andre Russowsky Brunoni, Manoel Jacobsen Teixeira, Rubens Gisbert Cury, Daniel Ciampi de Andrade
| Artículo siguiente Artículo siguiente
  • Romberg's test revisited: Changes in classical and advanced sway metrics in patients with pure sensory neuropathy
  • Evangelos Anagnostou, Maria Kouvli, Evangelia Karagianni, Anastasia Gamvroula, Theodosis Kalamatianos, George Stranjalis, Maria Skoularidou

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2025 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.